Skip to main content

Matrix Partners China — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

309
Companies
$7.0B
Total invested
$34.9M
Avg. check
49
Industries
Biotechnology 9Health Care 6Artificial Intelligence (AI) 4Pharmaceutical 4Manufacturing 4Robotics 4+43 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 309
Klook
February 2025

Klook is a travel and leisure booking platform designed to connect travelers with experiences and attractions.

Adventure Travel · Singapore$100.0M Series F
Lightelligence
September 2025

Harnessing light to power new possibilities

Artificial Intelligence (AI) · Boston$210.4M Series C
Smartpay
April 2024

Smartpay is a financial service company that helps consumers by offering standard paying, shopping, and consumer finance solutions.

E-Commerce · Tokyo$7.0M Seed
Rgenta Therapeutics
May 2023

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

Biotechnology · Cambridge$8.0M Series A
PAQ Therapeutics
January 2026

PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.

Biotechnology · Cambridge$38.0M Series B
Galaxy Jiutian
December 2023

Galaxy Jiutian is an aerospace technology developer specializing in aerospace technology as well as the marketing of aviation systems.

Aerospace · Kowloon City$100.0M Series A
LiveMe
January 2022

LiveMe is a live broadcasting app that lets you discover new content, find cool people, build a community, and earn cash rewards.

Broadcasting · Century CityVenture - Series Unknown
Chameleon Biosciences
November 2022

Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.

Biotechnology · San AnselmoSeed
Zerobase
October 2024

Zerobase is a real-time ZK prover network that prioritizes speed, decentralization, and regulatory compliance.

Blockchain · Los Altos$5.0M Seed
Futu Holdings
October 2022

Futu Holdings offers an online brokerage platform that enables individual investors to trade in listed stocks.

Financial Services · Hong KongPost-IPO Equity
Aeroband
March 2026

Aeroband is a manufacturer of air paddles and other musical instruments.

Manufacturing · Haidian$14.5M Series A
Galaxy Bot
March 2026

Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.

Artificial Intelligence (AI) · Beijing$363.9M Series Unknown
iSpace China
February 2026

iSpace designs and develops commercial space shuttle.

Aerospace · Beijing$727.6M Series D
Adlai Nortye
February 2026

Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.

Biotechnology · Hangzhou$140.0M Post Ipo Equity
Feijiecos
January 2026

Feijiecos is a smart technology supplier that specializes in smart technology and offers intelligent solutions.

Generative AI · Shanghai$14.4M Seed
Gongye Technology
January 2026

Gongye Technology makes use of AI and big data to manufacture intelligent equipment for solid waste sorting and recycling.

Artificial Intelligence (AI) · DongguangSeries C
INMO Glass
January 2026

INMO Glass are Foldable, monocular Augmented Reality (AR) glasses.

Augmented Reality · ShenzhenSeries C
Alioth
January 2026

Alioth focuses on the development and application of technical products for pharmaceutical process technology.

Biopharma · Shanghai$14.4M Series B
Weiyuan Synthetic Biotechnology
January 2026

Weiyuan Synthetic Biotechnology specializes in the manufacturing of food, feed and materials based on synthetic biology technology.

Biotechnology · Beijing$42.9M Series Unknown
Jiajin Biotech
December 2025

Jiajin Biotech is a pharmaceutical R&D service provider.

Biopharma · PudongSeries B
Noitom Robotics
December 2025

Noitom Robotics is an intelligent robot development company specializing in the sales, installation, and maintenance of industrial robots.

Robotics · BeijingSeed
KYinno
December 2025

KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.

Biotechnology · Beijing$35.5M Series B
D3 Bio
December 2025

D3 Bio is a biotechnology company focusing on the development and registration of medicines.

Biotechnology · Wuxi Shi$108.0M Series B
iOranges Automation
December 2025

iOranges Automation is an AI and robotics company.

Artificial Intelligence (AI) · ShenzhenSeries C

Where Matrix Partners China invests

Biotechnology9
Health Care6
Artificial Intelligence (AI)4
Pharmaceutical4
Manufacturing4
Robotics4

About Matrix Partners China's portfolio

How many companies has Matrix Partners China invested in?

Matrix Partners China has invested in 309 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Matrix Partners China invest in?

Matrix Partners China's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Pharmaceutical, Manufacturing. The firm invests across 49 different industry categories.

What is Matrix Partners China's largest investment?

Among tracked funding rounds, iSpace China received $727.6M in a Series D round. Matrix Partners China's total known invested capital is $7.0B.

What is the average investment size for Matrix Partners China?

Matrix Partners China's average investment size is $34.9M across its portfolio of 309 companies.

What are Matrix Partners China's most recent investments?

Recent Matrix Partners China portfolio additions include Klook, Lightelligence, Smartpay, Rgenta Therapeutics, PAQ Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 309 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →